Literature DB >> 6796772

Urinary pyrimidine excretion in arginase deficiency.

E W Naylor, S D Cederbaum.   

Abstract

A high-performance liquid-chromatographic method was used to separate and identify uracil, uridine, pseudouridine and orotic acid after preliminary extraction in two patients (McKusick 20780). Urinary uracil excretion was 10-35 times normal in both patients with arginase deficiency. Uridine and orotic acid, not normally detected, were excreted in large amounts and were directly influenced by protein intake. Their excretions were correlated with urinary arginine excretion. Urinary uracil levels remained consistently high and showed minimal variations with increased protein intake or urinary arginine levels. The measurement of urinary pyrimidines appears to be useful for the detection, differential diagnosis and dietary monitoring of patients with urea cycle disorders. The data presented extends this observation to include patients with arginase deficiency.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796772     DOI: 10.1007/BF02263653

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  THE EFFECT OF AMMONIA ADMINISTRATION ON OROTIC ACID EXCRETION IN RATS.

Authors:  L KESNER
Journal:  J Biol Chem       Date:  1965-04       Impact factor: 5.157

2.  Treatment of carbamyl phosphate synthetase deficiency with keto analogues of essential amino acids.

Authors:  M Batshaw; S Brusilow; M Walser
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

3.  Biochemical investigations of hyperammonaemia.

Authors:  B Levin; V G Oberholzer; L Sinclair
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

4.  Citrullinemia: investigation and treatment over a four-year period.

Authors:  N R Buist; N G Kennaway; C A Hepburn; J J Strandholm; D A Ramberg
Journal:  J Pediatr       Date:  1974-08       Impact factor: 4.406

5.  On the availability of intramitochondrial carbamoylphosphate for the extramitochondrial biosynthesis of pyrimidines.

Authors:  P J Natale; G C Tremblay
Journal:  Biochem Biophys Res Commun       Date:  1969-10-22       Impact factor: 3.575

6.  Hyperammonemia due to a defect in hepatic ornithine transcarbamylase.

Authors:  P Sunshine; J E Lindenbaum; H L Levy; J M Freeman
Journal:  Pediatrics       Date:  1972-07       Impact factor: 7.124

7.  Measurement of urinary pyrimidine bases and nucleosides by high-performance liquid chromatography.

Authors:  J E Evans; H Tieckelmann; E W Naylor; R Guthrie
Journal:  J Chromatogr       Date:  1979-05-01

8.  Argininemia treated from birth.

Authors:  S E Snyderman; C Sansaricq; P M Norton; F Goldstein
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

9.  Hyperargininemia with arginase deficiency.

Authors:  S D Cederbaum; K N Shaw; E B Spector; M A Verity; P J Snodgrass; G I Sugarman
Journal:  Pediatr Res       Date:  1979-07       Impact factor: 3.756

10.  Argininemia.

Authors:  S E Snyderman; C Sansaricq; W J Chen; P M Norton; S V Phansalkar
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

View more
  3 in total

1.  Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?

Authors:  Shailly Jain-Ghai; Sandesh C Sreenath Nagamani; Susan Blaser; Komudi Siriwardena; Annette Feigenbaum
Journal:  Mol Genet Metab       Date:  2011-07-13       Impact factor: 4.797

2.  Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet.

Authors:  S D Cederbaum; S J Moedjono; K N Shaw; M Carter; E Naylor; M Walzer
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

3.  Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders.

Authors:  Lindsay C Burrage; Lillian Thistlethwaite; Bridget M Stroup; Qin Sun; Marcus J Miller; Sandesh C S Nagamani; William Craigen; Fernando Scaglia; V Reid Sutton; Brett Graham; Adam D Kennedy; Aleksandar Milosavljevic; Brendan H Lee; Sarah H Elsea
Journal:  Genet Med       Date:  2019-01-23       Impact factor: 8.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.